These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3144048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Systemic fibrinolysis with recombinant tissue-type plasminogen activator in subrenal aortic occlusions].
    Hönigl K, Pilger E, Stark G, Bertuch H.
    Vasa Suppl; 1988; 26():99-102. PubMed ID: 3144050
    [No Abstract] [Full Text] [Related]

  • 3. Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis.
    Paramo JA, de Boer A, Colucci M, Jonker JJ, Collen D.
    Thromb Haemost; 1985 Oct 30; 54(3):725. PubMed ID: 3937271
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Selective thrombolysis of peripheral arterial occlusions using Rt-PA].
    Decrinis M, Pilger E, Stark G, Obernosterer A, Lafer M, Pieber D, Rumpl F, Lammer J.
    Vasa Suppl; 1990 Oct 30; 30():189-90. PubMed ID: 2127485
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Changes in plasma tissue plasminogen activator and plasminogen activator inhibitor in acute myocardial infarction and its clinical significance].
    Jia HY, Chen HZ, Pu SY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Aug 30; 16(4):214-6, 254. PubMed ID: 3147887
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of caffein ingestion on plasma fibrinolytic potential.
    Wojta J, Kirchheimer JC, Peska MG, Binder BR.
    Thromb Haemost; 1988 Apr 08; 59(2):337-8. PubMed ID: 3133816
    [No Abstract] [Full Text] [Related]

  • 11. Tissue plasminogen activator inhibitor in human plasma: development of a functional assay system and demonstration of a correlating Mr = 50,000 antiactivator.
    Korninger C, Wagner O, Binder BR.
    J Lab Clin Med; 1985 Jun 08; 105(6):718-24. PubMed ID: 3923146
    [Abstract] [Full Text] [Related]

  • 12. The role of the fibrinolytic system in thrombotic disease.
    Wiman B.
    Acta Med Scand Suppl; 1987 Jun 08; 715():169-71. PubMed ID: 3109214
    [No Abstract] [Full Text] [Related]

  • 13. [Local thrombolysis using a combination of RTPA and Lys-plasminogen in ischemia due to a previous thrombosis].
    Marcon JL, Annweiler M, Bonijoly S, Favre E.
    J Mal Vasc; 1989 Jun 08; 14(3):265-6. PubMed ID: 2506312
    [No Abstract] [Full Text] [Related]

  • 14. [50-year-old man with acute ischemia syndrome of both legs].
    von Scheidt W, Stäblein A, Autenrieth G.
    Internist (Berl); 1992 Apr 08; 33(4):265-8. PubMed ID: 1612851
    [No Abstract] [Full Text] [Related]

  • 15. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K, Rosc D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR.
    Thromb Haemost; 1988 Dec 22; 60(3):372-6. PubMed ID: 3149044
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, De Cock F, Collen D.
    Thromb Haemost; 1988 Oct 31; 60(2):247-50. PubMed ID: 3146141
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.